Abstract
In order to quantify the invasiveness of melanoma tumor cellsin vitro, a modification of the amniotic basement membrane (BM) model, described by Liottaet al. (Cancer Letters,11, 141, 1980), was used in combination with radiolabeled tumor cells. B16-F10 metastatic murine melanoma cells and a derived clone (B16-F10L) were prelabeled with 0·1 μCi/ml of [14C]thymidine for 20–24 h in serum-free medium at 37°C. Following incubation, fetal bovine serum was added to a concentration of 5 per cent, and the cells were allowed to grow to confluency for the next 24–28 h. The labeled cells were seeded onto amniotic membranes situated in Membrane Invasion Culture System (MICS) chambers at a density of 2·5×104 per well. At various times points, radioactivity of tumor cells that completely traversed the membrane was determined using an under-the-membrane sampling method. The average percent invasion demonstrated by the B16-F10 line was 2·75 per cent, and 3·65 per cent exhibited by the B16-F10L cell line after 48–53 hin vitro. Since it was apparent that some variability in thickness existed among membrane samples, a morphological analysis was performed on five sectors of a three-inch-diameter sample from four different placentae. Differences and similarities in BM thickness within the same sector were noted by this technique and could possibly contribute to some variability observed in tumor cell invasion in this model. Another parameter examined was the proliferation of tumor cells in the upper and lower wells of the MICS chambers. By 48 h, approximately 32·1 per cent of the B16-F10 cell line as well as the clone had replicated in the upper wells associated with the BMs compared with a 32·9 per cent replication in the lower wells, which reaffirmed the viability of the tumor cells under experimental conditions and insured similarly replicating populations of cells. In order to quantify the invasiveness of radiolabeled tumor cells accurately through a biological membranous barrier, the proper concentration of cells must be used, tumor cell heterogeneity should be taken into consideration, the technique of sampling radiolabeled invasive cells should be critically analysed, and thickness of the membranous barrier should all be considered as possible important factors in the quantitative analyses.
Similar content being viewed by others
References
Barsky, S. H., Siegal, G., Jannotta, F., andLiotta, L. A., 1983, Loss of basement membrane components by invasive tumors but not by their benign counterparts.Laboratory Investigation,49, 140–147.
Barsky, S. H., Togo, S., Garbisa, S., andLiotta, L. A., 1983, Type IV collagenase immunoreactivity in invasive breast carcinoma.Lancet,i, 296–297.
Blois, M. S., Sagebiel, R. W., Abarbanel, R. M., Caldwell, T. M., andTuttle, M. S., 1983, Malignant melanoma of the skin.Cancer,52, 1330–1341.
Burger, M. M., 1984, Experimental models for metastasis.Accomplishments in Cancer Research, edited by J. G. Fortner and J. E. Rhoads, (Philadelphia: Lippincott), pp. 174–182.
Fidler, I. J., 1973, Selection of successive tumor lines for metastasis.Nature New Biology,242, 148–149.
Fidler, I. J., Gersten, D. M., andHart, I. R., 1978, The biology of cancer invasion and metastasis.Advances in Cancer Research,28, 149–250.
Gehlsen, K. R., Wagner, H. N., Jr., andHendrix, M. J. C., 1984, Membrane invasion culture system (MICS).Medical Instrumentation,18, 268–271.
Gehlsen, K. R., Kischer, C. W., andHendrix, M. J. C., 1984, The utilization of neural crest cells as controls for melanoma tumor cell invasion through a basement membrane.Journal of Cell Biology,99, 335a.
Glassy, M. C., Handley, H. H., andRoyston, I., 1983, Human monoclonal antibodies to human cancers.Monoclonal Antibodies and Cancer, (New York: Academic Press), pp. 163–170.
Hamburger, A., andSalmon, S. E., 1977, Primary bioassay of human tumor stem cells.Science,197, 461–463.
Hart, I. R., andFidler, I. J., 1978, Anin vitro quantitative assay for tumor cell invasion.Cancer Research,38, 3218–3224.
Hendrix, M. J. C., 1984, A morphological characterization of melanoma tumor cell interaction with a basement membrane model in the absence and presence of an anticancer agent.Scanning Electron Microscopy,4, 1973–1982.
Hill, R. P., Chambers, A. F., andLing, V., 1984, Dynamic heterogeneity: Rapid generation of metastatic variants in mouse B16 melanoma cells.Science,224, 998–1001.
Ito, S., andKarnovsky, M. J., 1968, Formaldehyde-glutaraldehyde fixatives containing trinitro compounds.Journal of Cell Biology,39, 168a.
Lacovara, J., Cramer, E. B., andQuigley, J. P., 1984, Fibronectin enhancement of directed migration of B16 melanoma cells.Cancer Research,44, 1657–1663.
Liotta, L. A., Lee, C. W., andMorakis, D. J., 1980, New method for preparing large sufaces of intact human basement membrane for tumor invasion studies.Cancer Letters,11, 141–152.
Liotta, L. A., Thorgeirsson, U. P., andGarbisa, S., 1982, Role of collagenases in tumor cell invasion.Cancer Metastasis Reviews,1, 277–288.
Liotta, L. A., andHart, I. R., 1982,Invasion and Metastasis, (The Hague: Martinus Nijhoff).
Liotta, L. A. Rao, C. N., andBarsky, S. H., 1983, Tumor invasion and the extracellular matrix.Laboratory Investigation,49, 636–649.
Ludwig, R., Alberts, D. S., Miller, T. P., andSalmon, S. E., 1984, Evaluation of anti-cancer drug schedule dependency using anin vitro human tumor clonogenic assay.Cancer Chemotherapy and Pharmacology,12, 135–141.
Markus, G., Kohga, S., Camiolo, S. M., Madeja, J. M., Ambrus, J. L., andKrakousis, C., 1984, Plasminogen activators in human malignant melanoma.Journal of the National Cancer Institute,72, 1213–1222.
McCarthy, J. B., andFurcht, L. T., 1984, Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cellsin vitro.Journal of Cell Biology,98, 1474–1480.
Meyn, R. E., Hewitt, R. R., andHumphrey, R. M., 1973, Evaluation of S phase synchronization by analysis of DNA replication in 5-bromodeoxyuridine.Experimental Cell Research,82, 137–142.
Meyskens, F. L., Jr., Loescher, L., Moon, T. E., Takasugi, B., andSalmon, S. E., 1984, Relation ofin vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma.Journal of Clinical Oncology,2, 1223–1228.
Nicolson, G. L., 1984, Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity.Clinical and Experimental Metastasis,2, 85–105.
Nicolson, G. L., Brunson, K. W., andFidler, I. J., 1978, Specifically of arrest, survival, and growth of selected metastatic variant cell lines.Cancer Research,38, 4105–4111.
Parton, J. W.,Merriman, R. L., andTanzer, L. R., 1984, Anin vitro assay to quantitatively measure tumor cell invasion. FASCEB, 601a.
Pauli, B. U., Schwartz, D. E., Thonar, E. J. M., andKuettner, K. E., 1983, Tumor invasion and host extracellular matrix.Cancer Metastasis Reviews,2, 129–152.
Persky, V., Guzzino, K., Ostrowski, L., andSchultz, R. M., 1984, Inter-placental invasion rates for B16 F10 murine melanoma cells in the human amnion basement membrane model.Journal of Cell Biology,99, 335a.
Poste, G., 1982, Variation in the metastatic properties of cells from malignant tumors and the control of the metastatic phenotype.Tumour Progression and Markers, Proceedings of the Sixth Meeting of the European Association for Cancer Research (Amsterdam: Kugler Publications), pp. 197–210.
Poste, G., Doll, J., Brown, A. E., Tzeng, J., andZeidman, I., 1982, Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.Cancer Research,42, 2770–2778.
Poste, G., Doll, J., Hart, I. R., andFidler, I. J., 1980,In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.Cancer Research,40, 1636–1644.
Poste, G., andFidler, I. J., 1980, The pathogenesis of cancer metastasis.Nature,283, 139–146.
Russo, R. G., Liotta, L. A., Thorgeirsson, U., Brundage, R., andSchiffmann, E., 1981, Polymorphonuclear leukocyte migration through human amnion membrane.Journal of Cell Biology,91, 459–467.
Salmon, S. E., Hamburger, A. W., Soehnlen, B. J., Durie, B. G. M., Alberts, D. V., andMoon, T. E., 1978, Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs.New England Journal of Medicine,298, 1321–1327.
Salo, T., Liotta, L. A., Keski-Oja, J., Turpeenniemi-Hujanen, T., andTryggvason, K., 1982, Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells—role in metastasis.International Journal of Cancer,30, 669–673.
Schleich, A., Tchao, R., Frick, M., andMayer, A., 1981, Interaction of human carcinoma cells with an epithelial layer and the underlying basement membrane. A new model.Archiv fur Geschwulstforschung,51, 40–44.
Sheridan, J. W., andSimmons, R. J., 1981, Studies on a human melanoma cell line: Effect of cell crowding and nutrient depletion on the biophysical and kinetic characteristic of the cells.Journal of Cell Physiology,107, 85–100.
Snedecor, G. W., andCochran, W. G., 1967,Statistical Methods (Ames, Iowa: Iowa State University Press), pp. 135–198.
Tchao, R., Schleich, A. B., Frick, M., andMayer, A., 1980, A newin vitro model to study tumour cell invasion.Metastasis, Clinical and Experimental Aspects, edited by K. Hellmann, P. Hilgard and S. Eccles (The Hague: Martinus Nijhoff), pp. 28–32.
Thorgeirsson, U. P., Turpeenniemi-Hujanen, T., Neckers, L. M., Johnson, D. W., andLiotta, L. A., 1984, Protein synthesis but not DNA synthesis is required for tumor cells invasionin vitro.Invasion and Metastasis,4, 73–83.
Tveit, K. M., Fodstead, O., andPihl, A., 1981, The usefulness of human tumor cell lines in the study of chemosensitivity. A study of malignant melanomas.International Journal of Cancer,28, 403–408.
Weiss, L., andWard, P. M., 1983, Cell detachment and metastasis.Cancer Metastasis Reviews,2, 111–127.
Woolley, D. E., andGrafton, C. A., 1980, Collagenase immunolocalization studies of cutaneous secondary melanomas.British Journal of Cancer,42, 260–265.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hendrix, M.J.C., Gehlsen, K.R., Wagner, H.N. et al. In vitro quantification of melanoma tumor cell invasion. Clin Exp Metast 3, 221–233 (1985). https://doi.org/10.1007/BF01585078
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01585078